查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1808858

滴虫快速检测市场，按检测类型、样本类型、最终用户、国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Trichomonas Rapid Testing Market, By Test Type, By Sample Type, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 389 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年，滴虫快速检测市场规模价值 4.69 亿美元，2025 年至 2032 年的复合年增长率为 5.2%。

滴虫快速检测市场围绕着快速检测阴道滴虫感染（一种常见的性传染病）的诊断工具的开发、製造和终端用户。与传统的实验室方法相比，这些快速检测能够更快地获得结果，从而能够及时诊断和治疗。人们对性传染感染的认识不断提高，对生殖健康的重视程度不断提高，这推动了相关需求。分子诊断和即时检测设备的技术进步进一步拓展了市场机会。在临床环境中提供易于使用且经济高效的快速检测，可增强患者管​​理，尤其是在资源有限的环境中。

此外，全球性活跃人口的增加和医疗基础设施的改善也是推动因素。监管机构对加快诊断审批的支持正在加速市场成长。此外，旨在减少性传染感染传播的筛检活动和措施的增加也使市场受益。整体而言，市场正朝着更灵敏、更便利、更便携的检测解决方案发展。挑战包括需要更高的特异性和灵敏度以避免错误结果，以及其他诊断方法的竞争。

滴虫快速检测市场-市场动态

性传染感染盛行率的上升推动了对快速诊断的需求。

全球性传染病发生率的不断上升，迫切需要快速可靠的诊断工具。传统的检测方法通常需要较长的处理时间和专门的实验室基础设施，这可能会延迟诊断和治疗。快速检测毛滴虫感染可以帮助医护人员更有效地识别和管理病例，从而降低传播率。

早期发现对于控制疫情爆发和改善患者预后尤为重要。此外，性健康意识的提高以及政府支持的筛检计画也促进了这些快速检测的广泛应用。在资源匮乏、实验室设施匮乏的地区，这种需求更凸显，使得即时快速检测成为不可或缺的医疗保健工具。这项驱动力与遏制性传染感染传播和改善全球生殖健康的公共卫生目标紧密契合。

滴虫快速检测市场-关键见解

根据我们的研究分析师的分析，预计全球市场在预测期内（2025-2032 年）的年复合成长率约为 5.2%。

根据检测类型细分，预计分子快速检测将在 2024 年占据最大市场份额

根据样本类型细分，阴道/尿道拭子是 2024 年的主要样本类型

根据最终用户细分，医院是 2024 年的主要样本类型

按地区划分，北美是 2024 年的主要收入来源

滴虫快速检测市场-細項分析：

全球毛滴虫快速检测市场根据检测类型、样本类型、最终用户和地区进行细分。

根据检测类型，市场分为三类：分子快速检测、免疫层析检测和酵素连结免疫吸附试验。在检测类型中，分子快速检测因其在检测阴道毛滴虫方面卓越的准确性和灵敏度而占据市场主导地位。核酸扩增检测 (NAAT) 等分子方法即使在病原体含量较低的情况下也能提供可靠的检测，而免疫测定或层析检测可能会漏检这些情况。

这些检测週转时间短，可在护理点或护理点附近使用，因此在临床环境中颇具吸引力。儘管成本通常较高，但其临床效益和改善的患者预后证明，它们在医疗保健提供者中相当受欢迎。持续的进步使分子快速检测更加便捷易用，从而提高了采用率。此外，这些检测通常整合到可同时检测多种性传染感染的多重平台中，这进一步增强了它们的市场吸引力。

根据样本类型，市场分为两类：阴道/尿道拭子和尿液样本。在毛滴虫快速检测市场中，阴道拭子和尿道拭子是最主要的样本类型。这些拭子因其较高的诊断准确性，尤其是在与快速抗原和核酸扩增检测 (NAAT) 配合使用时，在临床环境中更受青睐。

它们广泛应用于医院、诊断实验室和性健康诊所，几分钟内即可提供可靠的结果。拭子检测的一致性和监管认可使其成为黄金标准，尤其适用于有症状的女性患者。虽然尿液样本因其非侵入性且适合在家检测而日益受到关注，但拭子凭藉其卓越的灵敏度和广泛的应用，仍保持领先地位。

滴虫快速检测市场-地理洞察

北美市场，尤其是美国和加拿大，是全球毛滴虫快速检测市场的重要贡献者。先进的医疗基础设施、快速诊断工具的广泛普及以及积极主动的政府筛检项目，共同推动了该地区的成长。拥有强大研发能力和终端用户网路的关键市场参与者的存在，为产品创新和可及性提供了支持。

针对性传播感染预防和早期诊断的公共卫生措施已完善，快速检测试剂盒的需求稳定。该地区也受益于患者认知度高以及支持诊断检测的保险覆盖政策。北美的监管框架鼓励快速审批新型检测技术，进一步推动了市场扩张。

美国凭藉其完善的医疗保健体系和日益重视的性健康筛检，在北美滴虫快速检测市场占据主导地位。该国为性传染感染（STI）防治计画提供了充足的资金，从而促进了对高效诊断解决方案的需求。大型医疗机构和诊所越来越多地采用快速检测技术，以提高患者吞吐量和临床疗效。包括基于核酸扩增的快速检测在内的技术创新日益普及，提高了灵敏度并简化了操作。

对降低医疗成本和减少就诊次数的日益关注也推动了即时检测的普及。市场参与者受益于FDA简化的监管途径，从而加快了新产品的上市速度。然而，替代检测方法的竞争以及持续产品验证的需求等挑战仍然存在。诊断公司与医疗保健机构之间的合作进一步增强了美国市场的成长潜力。

滴虫快速检测市场-竞争格局：

滴虫快速检测市场竞争激烈，主要参与者专注于产品创新、合作伙伴关係和策略性收购，以巩固其市场地位。各公司正在加大研发投入，以提高检测灵敏度、缩短週转时间并增强易用性。同时检测多种性传染感染的多重检测平台的趋势日益明显。市场参与者积极与医疗保健机构和政府机构合作，推广筛检计划，从而扩大其地理覆盖范围。

定价策略和报销政策对市场竞争有重大影响，促使参与者在成本效益和技术进步之间取得平衡。合规性和及时的产品审批是至关重要的竞争因素。规模较小的参与者通常专注于利基市场或区域市场，而规模较大的公司则利用广泛的终端用户网路和品牌知名度。总体而言，市场以持续创新和不断变化的客户需求为特征，推动竞争态势。

最新动态：

2025 年 5 月，Quidel 公司宣布推出改良的滴虫分子快速检测方法，该检测方法灵敏度更高，结果更快。

目录

第一章：滴虫快速检测市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 滴虫快速检测市场片段（依检测类型）
    • 滴虫快速检测市场片段（依样本类型）
    • 毛滴虫快速检测市场片段（按最终用户）
    • 滴虫快速检测市场（按国家/地区划分）
    • 毛滴虫快速检测市场（按地区）
  • 竞争洞察

第三章：滴虫快速检测关键市场趋势

  • 滴虫快速检测市场驱动因素
    • 市场驱动因素的影响分析
  • 滴虫快速检测市场限制
    • 市场限制的影响分析
  • 滴虫快速检测市场机会
  • 滴虫快速检测市场未来趋势

第四章：滴虫快速检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：滴虫快速侦测市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：滴虫快速侦测市场格局

  • 2024 年毛滴虫快速检测市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：滴虫快速侦测市场－依检测类型

  • 概述
    • 按测试类型分類的细分市场份额分析
    • 分子快速检测
    • 免疫层析测试
    • 酵素连结免疫吸附测定

第八章：滴虫快速检测市场－依样本类型

  • 概述
    • 依样本类型进行细分份额分析
    • 阴道/尿道拭子
    • 尿液样本

第九章：毛滴虫快速侦测市场－按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 诊断实验室
    • 诊所和医生办公室
    • 即时检验中心

第 10 章：毛滴虫快速侦测市场-依地域划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美滴虫快速检测主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按测试类型）
    • 北美市场规模和预测（按样本类型）
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲滴虫快速检测主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按测试类型）
    • 欧洲市场规模及预测（依样本类型）
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区滴虫快速检测主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依测试类型）
    • 亚太地区市场规模及预测（依样本类型）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲滴虫快速检测主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按测试类型）
    • 拉丁美洲市场规模及预测（依样本类型）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的滴虫快速检测主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依测试类型）
    • MEA 市场规模及预测（依样品类型）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章：主要供应商分析-毛滴虫快速检测产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Quidel Corporation
    • Hologic, Inc.
    • Sekisui Diagnostics
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Thermo Fisher Scientific
    • Bio-Rad Laboratories
    • Meridian Bioscience, Inc.
    • Siemens Healthineers
    • Roche Diagnostics
    • Alere Inc. (now part of Abbott)
    • Cepheid
    • F. Hoffmann-La Roche Ltd
    • Luminex Corporation
    • BioMerieux SA
    • Ortho Clinical Diagnostics
    • Mobidiag Oy
    • GenProbe, Inc.
    • Diasorin SpA
    • Nanosphere, Inc.

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5505

Trichomonas Rapid Testing Market size was valued at US$ 469 Million in 2024, expanding at a CAGR of 5.2% from 2025 to 2032.

The Trichomonas Rapid Testing Market revolves around the development, manufacturing, and End-user of diagnostic tools designed to quickly detect Trichomonas vaginalis infections, a common sexually transmitted infection. These rapid tests offer faster results compared to traditional laboratory-based methods, enabling timely diagnosis and treatment. Growing awareness of sexually transmitted infections and increased emphasis on reproductive health have fueled demand. Technological advancements in molecular diagnostics and point-of-care testing devices have further expanded market opportunities. The availability of easy-to-use, cost-effective rapid tests in clinical settings enhances patient management, especially in resource-limited environments.

Moreover, the rise in sexually active populations and improved healthcare infrastructure globally are contributing factors. Regulatory support for faster diagnostic approvals is accelerating market growth. The market also benefits from increased screening campaigns and initiatives aimed at reducing STI transmission. Overall, the market is progressing towards more sensitive, user-friendly, and portable testing solutions. Challenges include the need for high specificity and sensitivity to avoid false results and competition from alternative diagnostic methods.

Trichomonas Rapid Testing Market- Market Dynamics

Rising prevalence of sexually transmitted infections drives demand for rapid diagnostics.

The increasing incidence of sexually transmitted infections worldwide has created an urgent need for quick and reliable diagnostic tools. Traditional testing methods often require extended processing times and specialized laboratory infrastructure, which can delay diagnosis and treatment. Rapid testing for Trichomonas infections allows healthcare providers to identify and manage cases more efficiently, reducing transmission rates.

Early detection is particularly critical in controlling outbreaks and improving patient outcomes. Additionally, the rise in awareness about sexual health and government-supported screening programs promotes wider adoption of these rapid tests. This demand is amplified in low-resource settings where laboratory facilities are scarce, making point-of-care rapid tests an essential healthcare tool. The driver aligns closely with public health goals to curb STI spread and improve reproductive health globally.

Trichomonas Rapid Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.2% over the forecast period (2025-2032)

Based on Test Type segmentation, Molecular Rapid Tests were predicted to show maximum market share in the year 2024

Based on Sample Type segmentation, Vaginal/Urethral Swabs was the leading Sample Type in 2024

Based on End-user segmentation, Hospitals was the leading Sample Type in 2024

On the basis of region, North America was the leading revenue generator in 2024

Trichomonas Rapid Testing Market- Segmentation Analysis:

The Global Trichomonas Rapid Testing Market is segmented on the basis of Test Type, Sample Type, End-user, and Region.

The market is divided into three categories based on Test Type: Molecular Rapid Tests, Immunochromatographic Tests, and Enzyme Immunoassays. Among Test Types, Molecular Rapid Tests dominate the market due to their superior accuracy and sensitivity in detecting Trichomonas vaginalis. Molecular methods, such as nucleic acid amplification tests (NAATs), provide reliable detection even in cases of low pathogen load, which immunoassays or chromatographic tests may miss.

These tests offer rapid turnaround times and can be used at or near the point of care, making them attractive for clinical settings. Despite generally higher costs, the clinical benefits and improved patient outcomes justify their preference among healthcare providers. Continuous advancements have made molecular rapid tests more user-friendly and accessible, thus increasing adoption rates. Additionally, these tests are often integrated into multiplex platforms that detect multiple STIs simultaneously, further enhancing their market appeal.

The market is divided into two categories based on Sample Type: Vaginal/Urethral Swabs, Urine Samples. In the Trichomonas rapid testing market, vaginal and urethral swabs are the most dominant sample type. These swabs are preferred in clinical settings due to their high diagnostic accuracy, particularly when used with rapid antigen and nucleic acid amplification tests (NAATs).

They are widely adopted in hospitals, diagnostic labs, and sexual health clinics, offering reliable results within minutes. The consistency and regulatory acceptance of swab-based testing make it the gold standard, especially for symptomatic female patients. While urine samples are gaining traction for being non-invasive and suitable for at-home testing, swabs continue to lead due to their superior sensitivity and widespread usage.

Trichomonas Rapid Testing Market- Geographical Insights

The North American market, particularly the United States and Canada, is a significant contributor to the global Trichomonas rapid testing market. Advanced healthcare infrastructure, widespread availability of rapid diagnostic tools, and proactive government screening programs boost regional growth. The presence of key market players with strong R&D capabilities and End-user networks supports product innovation and accessibility.

Public health initiatives targeting STI prevention and early diagnosis are well-established, creating steady demand for rapid testing kits. The region also benefits from a high level of patient awareness and insurance coverage policies that support diagnostic testing. Regulatory frameworks in North America encourage rapid approvals of novel testing technologies, further driving market expansion.

The U.S. dominates the North American Trichomonas rapid testing market due to its sophisticated healthcare system and increasing emphasis on sexual health screening. The country has robust funding for STI prevention and control programs, fostering demand for efficient diagnostic solutions. Major healthcare providers and clinics increasingly adopt rapid testing to improve patient throughput and clinical outcomes. Technological innovation, including nucleic acid amplification-based rapid tests, is prevalent, offering enhanced sensitivity and ease of use.

The growing focus on reducing healthcare costs and hospital visits also encourages point-of-care testing adoption. Market players benefit from streamlined regulatory pathways by the FDA, facilitating quicker market entry for new products. However, challenges such as competition from alternative testing methods and the need for continuous product validation remain. Collaborations between diagnostic companies and healthcare organizations further strengthen the market's growth potential in the U.S.

Trichomonas Rapid Testing Market- Competitive Landscape:

The Trichomonas rapid testing market is highly competitive, with key players focusing on product innovation, partnerships, and strategic acquisitions to strengthen their market positions. Companies are investing in research and development to improve test sensitivity, reduce turnaround times, and enhance ease of use. The trend towards multiplex testing platforms that detect multiple sexually transmitted infections simultaneously is gaining traction. Market participants actively expand their geographic footprints by collaborating with healthcare providers and government bodies to promote screening initiatives.

Pricing strategies and reimbursement policies significantly impact market competition, encouraging players to balance cost-effectiveness with technological advancement. Regulatory compliance and timely product approvals are crucial competitive factors. Smaller players often focus on niche segments or regional markets, while larger companies leverage extensive End-user networks and brand recognition. Overall, the market is marked by continuous innovation and evolving customer needs, driving competitive dynamics.

Recent Developments:

In May 2025, Quidel Corporation announced the launch of an improved molecular rapid test for Trichomonas with enhanced sensitivity and faster results.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TRICHOMONAS RAPID TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Quidel Corporation
  • Hologic, Inc.
  • Sekisui Diagnostics
  • Abbott Laboratories
  • Becton Dickinson and Company
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Meridian Bioscience, Inc.
  • Siemens Healthineers
  • Roche Diagnostics
  • Alere Inc. (now part of Abbott)
  • Cepheid
  • F. Hoffmann-La Roche Ltd
  • Luminex Corporation
  • BioMerieux SA
  • Ortho Clinical Diagnostics
  • Mobidiag Oy
  • GenProbe, Inc.
  • Diasorin S.p.A
  • Nanosphere, Inc.

GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Molecular Rapid Tests
  • Immunochromatographic Tests
  • Enzyme Immunoassays

GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Vaginal/Urethral Swabs
  • Urine Samples

GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Clinics and Physician Offices
  • Point-of-Care Testing Centers

GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Trichomonas Rapid Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Trichomonas Rapid Testing Market Snippet by Test Type
    • 2.1.2. Trichomonas Rapid Testing Market Snippet by Sample Type
    • 2.1.3. Trichomonas Rapid Testing Market Snippet by End-user
    • 2.1.4. Trichomonas Rapid Testing Market Snippet by Country
    • 2.1.5. Trichomonas Rapid Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Trichomonas Rapid Testing Key Market Trends

  • 3.1. Trichomonas Rapid Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Trichomonas Rapid Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Trichomonas Rapid Testing Market Opportunities
  • 3.4. Trichomonas Rapid Testing Market Future Trends

4. Trichomonas Rapid Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Trichomonas Rapid Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Trichomonas Rapid Testing Market Landscape

  • 6.1. Trichomonas Rapid Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Trichomonas Rapid Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Molecular Rapid Tests
    • 7.1.3. Immunochromatographic Tests
    • 7.1.4. Enzyme Immunoassays

8. Trichomonas Rapid Testing Market - By Sample Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Sample Type, 2024 & 2032 (%)
    • 8.1.2. Vaginal/Urethral Swabs
    • 8.1.3. Urine Samples

9. Trichomonas Rapid Testing Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Clinics and Physician Offices
    • 9.1.5. Point-of-Care Testing Centers

10. Trichomonas Rapid Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Trichomonas Rapid Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Trichomonas Rapid Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Trichomonas Rapid Testing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Trichomonas Rapid Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Trichomonas Rapid Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Trichomonas Rapid Testing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Quidel Corporation
    • 11.2.2. Hologic, Inc.
    • 11.2.3. Sekisui Diagnostics
    • 11.2.4. Abbott Laboratories
    • 11.2.5. Becton Dickinson and Company
    • 11.2.6. Thermo Fisher Scientific
    • 11.2.7. Bio-Rad Laboratories
    • 11.2.8. Meridian Bioscience, Inc.
    • 11.2.9. Siemens Healthineers
    • 11.2.10. Roche Diagnostics
    • 11.2.11. Alere Inc. (now part of Abbott)
    • 11.2.12. Cepheid
    • 11.2.13. F. Hoffmann-La Roche Ltd
    • 11.2.14. Luminex Corporation
    • 11.2.15. BioMerieux SA
    • 11.2.16. Ortho Clinical Diagnostics
    • 11.2.17. Mobidiag Oy
    • 11.2.18. GenProbe, Inc.
    • 11.2.19. Diasorin S.p.A
    • 11.2.20. Nanosphere, Inc.

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us